Related references
Note: Only part of the references are listed.Lactate production is a prioritized feature of adipocyte metabolism
James R. Krycer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
The 3.2-Å resolution structure of human mTORC2
Alain Scaiola et al.
SCIENCE ADVANCES (2020)
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson's Disease
Zhou Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A novel rapamycin analog is highly selective for mTORC1 in vivo
Katherine H. Schreiber et al.
NATURE COMMUNICATIONS (2019)
Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes
Alison L. Kearney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters
Seong A. Kang et al.
CELL CHEMICAL BIOLOGY (2019)
Role of mTOR in Glucose and Lipid Metabolism
Zhuo Mao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Sarah J. Mahoney et al.
NATURE COMMUNICATIONS (2018)
Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
Haijuan Yang et al.
NATURE (2017)
The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
Mee-Sup Yoon
NUTRIENTS (2017)
Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification
Ignacio Arganda-Carreras et al.
BIOINFORMATICS (2017)
mTOR Signaling in Growth, Metabolism, and Disease (vol 168, pg 960, 2017)
Robert A. Saxton et al.
CELL (2017)
mTORC1 signaling and the metabolic control of cell growth
Issam Ben-Sahra et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma
Qiwen Fan et al.
CANCER CELL (2017)
STRUCTURAL BIOLOGY Architecture of human mTOR complex 1
Christopher H. S. Aylett et al.
SCIENCE (2016)
Nutrient-regulated Phosphorylation of ATG13 Inhibits Starvation-induced Autophagy
Cindy Puente et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa S. Rodrik-Outmezguine et al.
NATURE (2016)
mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2
KyeongJin Kim et al.
NATURE COMMUNICATIONS (2016)
Raptor/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease
Peter L. Lee et al.
MOLECULAR METABOLISM (2016)
mTORC1 Phosphorylates UVRAG to Negatively Regulate Autophagosome and Endosome Maturation
Young-Mi Kim et al.
MOLECULAR CELL (2015)
Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo
Maximilian Kleinert et al.
MOLECULAR METABOLISM (2014)
Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy
Hai-Xin Yuan et al.
AUTOPHAGY (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin
Seong A. Kang et al.
SCIENCE (2013)
A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products
James R. Krycer et al.
BIOCHEMICAL JOURNAL (2012)
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Brian Magnuson et al.
BIOCHEMICAL JOURNAL (2012)
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)
A. D. Barlow et al.
DIABETOLOGIA (2012)
mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes
Maria J. Pereira et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Dudley W. Lamming et al.
SCIENCE (2012)
Inducible raptor and rictor Knockout Mouse Embryonic Fibroblasts
Nadine Cybulski et al.
MTOR: METHODS AND PROTOCOLS (2012)
The Changing Role of mTOR Kinase in the Maintenance of Protein Synthesis during Human Cytomegalovirus Infection
Amy J. Clippinger et al.
JOURNAL OF VIROLOGY (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling
Yonghao Yu et al.
SCIENCE (2011)
The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
Peggy P. Hsu et al.
SCIENCE (2011)
Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster
Ivana Bjedov et al.
CELL METABOLISM (2010)
DAP1, a Novel Substrate of mTOR, Negatively Regulates Autophagy
Itay Koren et al.
CURRENT BIOLOGY (2010)
Fat Cell-Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism
Anil Kumar et al.
DIABETES (2010)
Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis
M. D. Lacher et al.
ONCOGENE (2010)
Rapamycin inhibits mTORC1, but not completely
Carson C. Thoreen et al.
AUTOPHAGY (2009)
ULK1•ATG13•FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy
Ian G. Ganley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nutrient-dependent mTORC1 Association with the ULK1-Atg13-FIP200 Complex Required for Autophagy
Nao Hosokawa et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Chang Hwa Jung et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
Sirolimus is associated with new-onset diabetes in kidney transplant recipients
Olwyn Johnston et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Andrew Y. Choo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity
Nancy Luong et al.
CELL METABOLISM (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
4E-BP functions as a metabolic brake used under stress conditions but not during normal growth
AA Teleman et al.
GENES & DEVELOPMENT (2005)
Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes
F Tremblay et al.
ENDOCRINOLOGY (2005)
Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control
M Ohanna et al.
NATURE CELL BIOLOGY (2005)
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies
OJ Shah et al.
CURRENT BIOLOGY (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
Share Paper
